Literature DB >> 12095803

Pathological study of cases with secondary open-angle glaucoma due to sarcoidosis.

Teruhiko Hamanaka1, Ayumi Takei, Tamiko Takemura, Masaru Oritsu.   

Abstract

PURPOSE: To investigate the cause of secondary open-angle glaucoma due to sarcoidosis.
DESIGN: Observational case series studied by histological methods.
METHODS: Seven trabeculectomy specimens from six patients with secondary open-angle glaucoma due to ocular sarcoidosis (trabeculectomy group) and anterior parts of seven autopsy eyes from four patients (autopsy eye group) diagnosed as confirmed sarcoidosis were processed for light and transmission electron microscopy. Pathological changes of outflow routes were investigated.
RESULTS: Granulomata were found in three eyes of the trabeculectomy group and in three eyes of the autopsy eye group. Part of the Schlemm canal was occluded and replaced by fibrotic tissue and it became narrow in four eyes of the trabeculectomy group and three eyes of the autopsy eye group. The spaces of the trabecular meshwork appeared wide, even in the area close to granulomata and peripheral anterior synechia of the iris. Infiltration of lymphocytes, monocytes, and macrophages around the Schlemm canal was found in all eyes of the trabeculectomy group and in four eyes of the autopsy eye group. The infiltration of these cells was observed not only in the inner wall, but also in the posterior outer wall of the Schlemm canal and the collector channels.
CONCLUSION: "Schlemm canalitis" is proposed from the results of inflammatory cell infiltration around the wall of the canal. The occlusion of the Schlemm canal by granulomata or fibrotic tissue replacement of the canal may play an important role in secondary open-angle glaucoma due to sarcoidosis.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12095803     DOI: 10.1016/s0002-9394(02)01507-6

Source DB:  PubMed          Journal:  Am J Ophthalmol        ISSN: 0002-9394            Impact factor:   5.258


  9 in total

Review 1.  Cutaneous sarcoidosis and secondary open-angle glaucoma in a patient: case report and literature review.

Authors:  Qiancheng Deng; Shu Ding; Shengbo Yang; JinHua Huang
Journal:  An Bras Dermatol       Date:  2017 May-Jun       Impact factor: 1.896

2.  Efficacy and safety of ripasudil, a Rho-associated kinase inhibitor, in eyes with uveitic glaucoma.

Authors:  Sentaro Kusuhara; Atsuko Katsuyama; Wataru Matsumiya; Makoto Nakamura
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2018-02-21       Impact factor: 3.117

3.  Cell atlas of aqueous humor outflow pathways in eyes of humans and four model species provides insight into glaucoma pathogenesis.

Authors:  Tavé van Zyl; Wenjun Yan; Alexi McAdams; Yi-Rong Peng; Karthik Shekhar; Aviv Regev; Dejan Juric; Joshua R Sanes
Journal:  Proc Natl Acad Sci U S A       Date:  2020-04-27       Impact factor: 11.205

Review 4.  [Sarcoidosis and uveitis : An update].

Authors:  J G Garweg
Journal:  Ophthalmologe       Date:  2017-06       Impact factor: 1.059

5.  [Bilateral recurrent blurred vision associated with halos around sources of light and headache].

Authors:  D Völcker; T Reinhard; T Ness
Journal:  Ophthalmologe       Date:  2012-04       Impact factor: 1.059

Review 6.  [Ocular sarcoidosis].

Authors:  C Springer-Wanner; T Brauns
Journal:  Z Rheumatol       Date:  2017-06       Impact factor: 1.372

Review 7.  Gender and ocular manifestations of connective tissue diseases and systemic vasculitides.

Authors:  Maria M Choudhary; Rula A Hajj-Ali; Careen Y Lowder
Journal:  J Ophthalmol       Date:  2014-03-17       Impact factor: 1.909

Review 8.  Sarcoid Uveitis: An Intriguing Challenger.

Authors:  Pia Allegri; Sara Olivari; Federico Rissotto; Roberta Rissotto
Journal:  Medicina (Kaunas)       Date:  2022-07-04       Impact factor: 2.948

9.  Comparison of ab externo trabeculotomy in primary open-angle glaucoma and uveitic glaucoma: long-term outcomes.

Authors:  Antony William; Martin S Spitzer; Deshka Doycheva; Spyridon Dimopoulos; Martin Alexander Leitritz; Bogomil Voykov
Journal:  Clin Ophthalmol       Date:  2016-05-23
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.